Proffitt & Goodson Inc Pfizer Inc Transaction History

Proffitt & Goodson Inc

$607 Million
Q3 2024

A detailed history of Proffitt & Goodson Inc transactions in Pfizer Inc stock. As of the latest transaction made, Proffitt & Goodson Inc holds 3,449 shares of PFE stock, worth $90,501. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,449

Previous 3,443 0.17%

Holding current value

$90,501

Previous $96,000 3.13%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $166 - $188	6 Added 0.17%	3,449 $99,000
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $3,031 - $3,552	-120 Reduced 3.37%	3,443 $96,000
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $27,650 - $31,751	1,068 Added 42.81%	3,563 $98,000
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $10,452 - $13,576	400 Added 19.09%	2,495 $71,000
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $673,601 - $787,372	-20,991 Reduced 90.93%	2,095 $69,000
Q2 2023 Jul 18, 2023	BUY	$36.12 - $41.79 $14,845 - $17,175	411 Added 1.81%	23,086 $846,000
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $5,761 - $7,521	138 Added 0.61%	22,675 $0
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $13,828 - $16,880	316 Added 1.42%	22,537 $986,000
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $3,861 - $4,579	-83 Reduced 0.37%	22,221 $1.17 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $62,403 - $77,325	-1,364 Reduced 5.76%	22,304 $1.16 Million
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $157,718 - $233,791	3,817 Added 19.23%	23,668 $1.4 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $5,141 - $6,605	-131 Reduced 0.66%	19,851 $854,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $57,096 - $64,681	1,590 Added 8.65%	19,982 $782,000
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $1,306 - $1,473	39 Added 0.21%	18,392 $666,000
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $57,869 - $73,586	1,729 Added 10.4%	18,353 $676,000
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $73,787 - $86,569	2,324 Added 16.25%	16,624 $610,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $2,439 - $2,959	81 Added 0.57%	14,300 $468,000
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $143,799 - $205,458	-5,320 Reduced 27.23%	14,219 $464,000
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $178,360 - $202,416	-5,418 Reduced 21.71%	19,539 $766,000
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $112,675 - $146,106	3,468 Added 16.14%	24,957 $897,000
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $1,590 - $1,785	-43 Reduced 0.2%	21,489 $931,000
Q1 2019 Apr 18, 2019	BUY	$37.5 - $41.2 $804,900 - $884,316	21,464 Added 31564.71%	21,532 $914,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $2,343 - $2,843	68 New	68 $3,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Proffitt & Goodson Inc with notifications on news.

Account

Proffitt & Goodson Inc Pfizer Inc Transaction History